InsightRX Achieves High Performance Score in KLAS Spotlight

October 07, 2025
InsightRX, a leader in precision dosing AI solutions, has been recognized in the 2025 KLAS Emerging Company Spotlight report with a performance score of 96.1, highlighting its impact on clinical decision support.

InsightRX has been recognized in the 2025 KLAS Emerging Company Spotlight report with a performance score of 96.1, announced in a press release. This score places InsightRX among the highest-rated vendors in clinical decision support, emphasizing its ability to enhance clinician experience, support seamless EHR integration, and deliver measurable patient outcomes.

The KLAS report highlighted InsightRX's strengths in several key areas, including integration goals, product functionality, and executive involvement. Customers reported a 100% likelihood to recommend the solution and include it in long-term plans. The platform has demonstrated significant outcomes, such as decreased medication side effects and reduced rates of acute kidney injury within six months of adoption.

Looking ahead, InsightRX is expanding its platform to cover new drug classes and therapeutic areas. The company is developing a next-generation clinical decision support tool that combines PK/PD modeling with broader clinical context inputs, aiming to optimize stewardship programs and integrate genomic data into routine care.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

10/08
BD and Opentrons Collaborate on Robotic Automation for Single-Cell Multiomics
10/08
POMDOCTOR Limited Prices IPO on Nasdaq
10/08
TransCelerate Advances Digital Protocols in Clinical Trials
10/07
Qualtrics to Acquire Press Ganey Forsta for $6.75 Billion
10/06
AstraZeneca and Algen Biotechnologies Partner for AI-Driven Gene-Editing Therapies

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like